Abstract
Previous studies have indicated that children with inflammatory bowel disease (IBD) may not achieve optimal bone mass. We evaluated the skeletal characteristics in children and adolescents with IBD. This cross-sectional cohort study comprised 80 IBD patients (median age 14.9 years, range 5–20) with a median disease duration of 3.4 years; 51 had ulcerative colitis, 26 Crohn disease, and 3 unspecified colitis. Eighty age- and gender-matched healthy subjects served as controls. Areal bone mineral density (aBMD), body composition, and vertebral fractures (VFs) were assessed by DXA. Bone age (BA) was determined for IBD patients. Findings were correlated with disease- and treatment-related parameters and biochemistry. IBD patients had lower BA-adjusted lumbar spine and whole-body aBMD (p < 0.001 for both) and whole-body BMC adjusted for height (p = 0.02) than controls. Lean mass and fat mass Z scores did not differ between the groups, but IBD patients had lower whole-body BMC relative to muscle mass (p = 0.006). Despite vitamin D supplementation in 48 %, vitamin D deficiency was common. In IBD cumulative weight-adjusted prednisolone dose >150 mg/kg for the preceding 3 years increased the risk for low whole-body aBMD (OR = 5.5, 95 % CI 1.3–23.3, p = 0.02). VFs were found in 11 % of patients and in 3 % of controls (p = 0.02). IBD in childhood was associated with low aBMD and reduced bone mass accrual relative to muscle mass; the risk for subclinical VFs may be increased. These observations warrant careful follow-up and active preventive measures.
Similar content being viewed by others
References
Pappa H, Thayu M, Sylvester F, Leonard M, Zemel B, Gordon C (2011) Skeletal health of children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 53:11–25
Burnham JM, Shults J, Semeao E, Foster B, Zemel BS, Stallings VA, Leonard MB (2004) Whole body BMC in pediatric Crohn disease: independent effects of altered growth, maturation, and body composition. J Bone Miner Res 19:1961–1968
Schmidt S, Mellström D, Norjavaara E, Sundh SV, Saalman R (2009) Low bone mineral density in children and adolescents with inflammatory bowel disease: a population-based study from western Sweden. Inflamm Bowel Dis 15:1844–1850
Dubner SE, Shults J, Baldassano RN, Zemel BS, Thayu M, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn’s disease. Gastroenterology 136:123–130
Ward LM, Rauch F, Matzinger MA, Benchimol EI, Boland M, Mack DR (2010) Iliac bone histomorphometry in children with newly diagnosed inflammatory bowel disease. Osteoporos Int 21:331–337
Werkstetter KJ, Pozza SB, Filipiak-Pittroff B, Schatz SB, Prell C, Bufler P, Koletzko B, Koletzko S (2011) Long-term development of bone geometry and muscle in pediatric inflammatory bowel disease. Am J Gastroenterol 106:988–998
Tuchman S, Thayu M, Shults J, Zemel BS, Burnham JM, Leonard MB (2008) Interpretation of biomarkers of bone metabolism in children: impact of growth velocity and body size in healthy children and chronic disease. J Pediatr 153:484–490
Hill RJ, Brookes DS, Davies PS (2011) Bones in pediatric Crohn’s disease: a review of fracture risk in children and adults. Inflamm Bowel Dis 17:1223–1228
Kappelman MD, Galanko JA, Porter CQ, Sandler RS (2011) Risk of diagnosed fractures in children with inflammatory bowel diseases. Inflamm Bowel Dis 17:1125–1130
Semeao EJ, Stallings VA, Peck SN, Piccoli DA (1997) Vertebral compression fractures in pediatric patients with Crohn’s disease. Gastroenterology 112:1710–1713
Klaus J, Armbrecht G, Steinkamp M, Bruckel J, Rieber A, Adler G, Reinshagen M, Felsenberg D, von Tirpitz C (2002) High prevalence of osteoporotic vertebral fractures in patients with Crohn’s disease. Gut 51:654–658
Sbrocchi AM, Forget S, Laforte D, Azouz EM, Rodd C (2010) Zoledronic acid for the treatment of osteopenia in pediatric Crohn’s disease. Pediatr Int 52:754–761
Thayu M, Shults J, Burnham JM, Zemel BS, Baldassano RN, Leonard MB (2007) Gender differences in body composition deficits at diagnosis in children and adolescents with Crohn’s disease. Inflamm Bowel Dis 13:1121–1128
Sylvester FA, Leopold S, Lincoln M, Hyams JS, Griffiths AM, Lerer T (2009) A two-year longitudinal study of persistent lean tissue deficits in children with Crohn’s disease. Clin Gastroenterol Hepatol 7:452–455
Thayu M, Denson LA, Shults J, Zemel BS, Burnham JM, Baldassano RN, Howard KM, Ryan A, Leonard MB (2010) Determinants of changes in linear growth and body composition in incident pediatric Crohn’s disease. Gastroenterology 139:430–438
Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS (1998) Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology 114:902–911
Hill RJ, Brookes DS, Lewindon PJ, Withers GD, Ee LC, Connor FL, Cleghorn GJ, Davies PS (2009) Bone health in children with inflammatory bowel disease: adjusting for bone age. J Pediatr Gastroenterol Nutr 48:538–543
Lennard-Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 170(2–6):16–19
Viljakainen HT, Pekkinen M, Saarnio E, Karp H, Lamberg-Allardt C, Mäkitie O (2011) Dual effect of adipose tissue on bone health during growth. Bone 48:212–217
Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, Griffiths AM, Katz AJ, Grand RJ, Boyle JT (1991) Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr 12:439–447
Turner D, Otley AR, Mack D, Hyams J, de Bruijne J, Uusoue K, Walters TD, Zachos M, Mamula P, Beaton DE, Steinhart AH, Griffiths AM (2007) Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology 133:423–432
Tanner JM (1962) Growth at adolescence: with a general consideration of the effects of hereditary and environmental factors upon growth and maturation from birth to maturity, 2nd edn. Blackwell, Oxford
Sorva R, Lankinen S, Tolppanen EM, Perheentupa J (1990) Variation of growth in height and weight of children. II. After infancy. Acta Paediatr Scand 79:498–506
Pere A (2000) Comparison of two methods for transforming height and weight to normality. Ann Hum Biol 27:35–45
Cole TJ, Freeman JV, Preece MA (1995) Body mass index reference curves for the UK, 1990. Arch Dis Child 73:25–29
Greulich WW, Pyle SI (1959) Radiographic atlas of skeletal development of the hand and wrist, 2nd edn. Stanford University Press, Stanford, CA
Kalkwarf HJ, Zemel BS, Gilsanz V, Lappe JM, Horlick M, Oberfield S, Mahboubi S, Fan B, Frederick MM, Winer K, Shepherd JA (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92:2087–2099
Zemel BS, Leonard MB, Kelly A, Lappe JM, Gilsanz V, Oberfield S, Mahboubi S, Shepherd JA, Hangartner TN, Frederick MM, Winer KK, Kalkwarf HJ (2010) Height adjustment in assessing dual energy X-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95:1265–1273
Kelly TL, Wilson KE, Heymsfield SB (2009) Dual energy X-ray absorptiometry body composition reference values from NHANES. PLoS One 4:e7038
Mäkitie O, Doria AS, Henriques F, Cole WG, Compeyrot S, Silverman E, Laxer R, Daneman A, Sochett EB (2005) Radiographic vertebral morphology: a diagnostic tool in pediatric osteoporosis. J Pediatr 146:395–401
Sylvester FA, Wyzga N, Hyams JS, Davis PM, Lerer T, Vance K, Hawker G, Griffiths AM (2007) Natural history of bone metabolism and bone mineral density in children with inflammatory bowel disease. Inflamm Bowel Dis 13:42–50
Pappa HM, Saslowsky TM, Filip-Dhima R, DiFabio D, Lahsinoui HH, Akkad A, Grand RJ, Gordon CM (2011) Efficacy and harms of nasal calcitonin in improving bone density in young patients with inflammatory bowel disease: a randomized, placebo-controlled, double-blind trial. Am J Gastroenterol 106:1527–1543
Griffiths AM, Nguyen P, Smith C, MacMillan JH, Sherman PM (1993) Growth and clinical course of children with Crohn’s disease. Gut 34:939–943
Bechtold S, Alberer M, Arenz T, Putzker S, Filipiak-Pittroff B, Schwarz HP, Koletzko S (2010) Reduced muscle mass and bone size in pediatric patients with inflammatory bowel disease. Inflamm Bowel Dis 16:216–225
Valta H, Jalanko H, Holmberg C, Helenius I, Mäkitie O (2008) Impaired bone health in adolescents after liver transplantation. Am J Transplant 8:150–157
Valta H, Mäkitie O, Rönnholm K, Jalanko H (2009) Bone health in children and adolescents after renal transplantation. J Bone Miner Res 24:1699–1708
Mäyränpää MK, Helenius I, Valta H, Mäyränpää MI, Toiviainen-Salo S, Mäkitie O (2007) Bone densitometry in the diagnosis of vertebral fractures in children: accuracy of vertebral fracture assessment. Bone 41:353–359
Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319–1328
Burnham JM, Shults J, Semeao E, Foster BJ, Zemel BS, Stallings VA, Leonard MB (2005) Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr 82:413–420
Pappa HM, Gordon CM, Saslowsky TM, Zholudev A, Horr B, Shih MC, Grand RJ (2006) Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 118:1950–1961
Pappa HM, Langereis EJ, Grand RJ, Gordon CM (2011) Prevalence and risk factors for hypovitaminosis D in young patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 53:361–364
Acknowledgement
We thank research nurse Päivikki Rissanen for her skillful assistance. This study was supported by grants from the Sigrid Juselius Foundation, the Finnish Medical Foundation, the Finnish Foundation for Pediatric Research, the Academy of Finland, and the Helsinki University Hospital Research Funds.
Author information
Authors and Affiliations
Corresponding author
Additional information
The authors have stated that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Laakso, S., Valta, H., Verkasalo, M. et al. Impaired Bone Health in Inflammatory Bowel Disease: A Case–Control Study in 80 Pediatric Patients. Calcif Tissue Int 91, 121–130 (2012). https://doi.org/10.1007/s00223-012-9617-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-012-9617-2